← Leaderboards
Benhur Lee
University Of Pennsylvania
$26,036,912
Attributed
$28,228,947
Total exposure
17
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,228,947 · 17
By mechanism
R01$12,233,768 · 6
U01$5,757,163 · 2
U19$5,393,007 · 1
R21$2,411,021 · 5
U54$1,266,543 · 1
R37$805,375 · 1
Top collaborators
- Dong Sung An5 shared
- Jean Kyou Lim3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Gary Smith$1,414,366
- Sara Cherry$26,280,643
- Paul F Bates$14,487,725
- Casey H Londergan$596,760
- Mark Dennis Dittmar$49,538
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusViralPathogenParamyxovirusHenipavirusHendra VirusProteinsCellsVirus DiseasesMediatingResourcesLifeInfectionNipah VirusNational Institute Of Allergy And Infectious DiseaseReceptor BindingBaseTransmission ProcessComplexResearch PersonnelTransfectionSmall MoleculeAnimalsBiodefense
Grant awards (55)
Development of broadly neutralizing human monoclonal antibodies against henipaviruses$809,614
R01 · FY2025 · AI · contact PI
Understanding the Tropism and Pathogenesis of Pararubulaviruses$805,375
R37 · FY2025 · AI · contact PI
Project 3 â Direct-Acting Antivirals against Paramyxoviruses$5,393,007
U19 · FY2022 · AI · contact PI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$616,616
R01 · FY2022 · AI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$625,091
R01 · FY2021 · AI
Human Parainfluenza Virus 3 Infection in a Novel Human Lung Tissue Model$210,302
R21 · FY2021 · AI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$625,091
R01 · FY2020 · AI
Tropism, pathogenicity, and potential for zoonotic spillover of emergent henipa- and henipa-like viruses$535,651
R01 · FY2020 · AI · contact PI
SUMO and ubiquitin modifications in henipavirus matrix trafficking and function$420,125
R01 · FY2020 · AI · contact PI
Human Parainfluenza Virus 3 Infection in a Novel Human Lung Tissue Model$252,677
R21 · FY2020 · AI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$633,566
R01 · FY2019 · AI
Tropism, pathogenicity, and potential for zoonotic spillover of emergent henipa- and henipa-like viruses$584,782
R01 · FY2019 · AI · contact PI
SUMO and ubiquitin modifications in henipavirus matrix trafficking and function$416,250
R01 · FY2019 · AI · contact PI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$615,353
R01 · FY2018 · AI
Tropism, pathogenicity, and potential for zoonotic spillover of emergent henipa- and henipa-like viruses$589,331
R01 · FY2018 · AI · contact PI
SUMO and ubiquitin modifications in henipavirus matrix trafficking and function$416,250
R01 · FY2018 · AI · contact PI
Tropism, pathogenicity, and potential for zoonotic spillover of emergent henipa- and henipa-like viruses$519,630
R01 · FY2017 · AI · contact PI
SUMO and ubiquitin modifications in henipavirus matrix trafficking and function$433,625
R01 · FY2017 · AI · contact PI
Tropism, pathogenicity, and potential for zoonotic spillover of emergent henipa- and henipa-like viruses$492,738
R01 · FY2016 · AI · contact PI
SUMO and ubiquitin modifications in henipavirus matrix trafficking and function$437,250
R01 · FY2016 · AI · contact PI
Functional interrogation of paramyxovirus genomes with efficient reverse genetics$208,782
R21 · FY2016 · AI · contact PI
Functional interrogation of paramyxovirus genomes with efficient reverse genetics$251,157
R21 · FY2015 · AI · contact PI
Platforms for structure-function studies of entry and budding of viral zoonotic$223,897
U54 · FY2013 · AI · contact PI
Broad spectrum therapeutics that target the viral membrane$741,062
U01 · FY2012 · AI · contact PI
Platforms for structure-function studies of entry and budding of viral zoonotic$223,482
U54 · FY2012 · AI · contact PI
Broad spectrum therapeutics that target the viral membrane$741,357
U01 · FY2011 · AI · contact PI
Envelope-receptor interactions in Nipah and Hendra virus pathobiology$326,031
R01 · FY2011 · AI · contact PI
Platforms for structure-function studies of entry and budding of viral zoonotic$275,091
U54 · FY2011 · AI · contact PI
Quantifying differential CD4 and CCR5 usage patterns amongst HIV-1/SIV strains$190,575
R21 · FY2011 · AI · contact PI
Broad spectrum therapeutics that target the viral membrane$750,371
U01 · FY2010 · AI · contact PI
Envelope-receptor interactions in Nipah and Hendra virus pathobiology$329,309
R01 · FY2010 · AI · contact PI
Platforms for structure-function studies of entry and budding of viral zoonotic$269,325
U54 · FY2010 · AI · contact PI
Quantifying differential CD4 and CCR5 usage patterns amongst HIV-1/SIV strains$231,000
R21 · FY2010 · AI · contact PI
Broad spectrum therapeutics that target the viral membrane$738,186
U01 · FY2009 · AI · contact PI
Small Molecule Inhibitors of Nipah and Hendra Virus Infection$682,624
U01 · FY2009 · AI · contact PI
Envelope-receptor interactions in Nipah and Hendra virus pathobiology$334,819
R01 · FY2009 · AI · contact PI
Platforms for structure-function studies of entry and budding of viral zoonotic$274,748
U54 · FY2009 · AI · contact PI
Small Molecule Inhibitors of Nipah and Hendra Virus Infection$715,954
U01 · FY2008 · AI · contact PI
Envelope-receptor interactions in Nipah and Hendra virus pathobiology$332,651
R01 · FY2008 · AI · contact PI
Small Molecule Inhibitors of Nipah and Hendra Virus Infection$722,322
U01 · FY2007 · AI · contact PI
Envelope-receptor interactions in Nipah and Hendra virus pathobiology$339,094
R01 · FY2007 · AI · contact PI
Small Molecule Inhibitors of Nipah and Hendra Virus Infection$665,287
U01 · FY2006 · AI · contact PI
Studies on DC-SIGN Interactions with HIV and SIV$368,339
R01 · FY2006 · AI · contact PI
Studies on DC-SIGN Interactions with HIV and SIV$377,203
R01 · FY2005 · AI
A reverse genetic system for the study of Nipah Virus$305,485
R21 · FY2005 · AI
Studies on DC-SIGN Interactions with HIV and SIV$377,203
R01 · FY2004 · AI
A reverse genetic system for the study of Nipah Virus$303,543
R21 · FY2004 · AI
Peptidomimics of DC-SIGN binding structures on gp120$228,750
R21 · FY2004 · AI
Studies on DC-SIGN Interactions with HIV and SIV$377,203
R01 · FY2003 · AI
Peptidomimics of DC-SIGN binding structures on gp120$228,750
R21 · FY2003 · AI
Studies on DC-SIGN Interactions with HIV and SIV$300,953
R01 · FY2002 · AI
HIV 1 CORECEPTORS AND THEIR ROLE IN HEMATOPOIESIS$120,690
K08 · FY2002 · HL
HIV 1 CORECEPTORS AND THEIR ROLE IN HEMATOPOIESIS$120,690
K08 · FY2001 · HL
HIV 1 CORECEPTORS AND THEIR ROLE IN HEMATOPOIESIS$62,640
K08 · FY2000 · HL
HIV 1 CORECEPTORS AND THEIR ROLE IN HEMATOPOIESIS$58,050
K08 · FY2000 · HL